These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 25681427

  • 61. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K, Sung RY, Huang WZ, Yang M, Pong NH, Lee SM, Chan WY, Zhao H, To MY, Fok TF, Li CK, Wong YO, Ng PC.
    Circulation; 2006 May 09; 113(18):2211-20. PubMed ID: 16651473
    [Abstract] [Full Text] [Related]

  • 62. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
    Qi W, Boliang W, Xiaoxi T, Guoqiang F, Jianbo X, Gang W.
    Biomed Pharmacother; 2020 Feb 09; 122():109547. PubMed ID: 31918264
    [Abstract] [Full Text] [Related]

  • 63. Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
    Ikeda Y, Aihara K, Akaike M, Sato T, Ishikawa K, Ise T, Yagi S, Iwase T, Ueda Y, Yoshida S, Azuma H, Walsh K, Tamaki T, Kato S, Matsumoto T.
    Mol Endocrinol; 2010 Jul 09; 24(7):1338-48. PubMed ID: 20501642
    [Abstract] [Full Text] [Related]

  • 64. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.
    Lue Y, Gao C, Swerdloff R, Hoang J, Avetisyan R, Jia Y, Rao M, Ren S, Atienza V, Yu J, Zhang Y, Chen M, Song Y, Wang Y, Wang C.
    Am J Physiol Heart Circ Physiol; 2018 Sep 01; 315(3):H634-H643. PubMed ID: 29775411
    [Abstract] [Full Text] [Related]

  • 65. Apelin/APJ system: a promising therapy target for hypertension.
    Wu D, He L, Chen L.
    Mol Biol Rep; 2014 Oct 01; 41(10):6691-703. PubMed ID: 24990699
    [Abstract] [Full Text] [Related]

  • 66. Lactation Is a Risk Factor of Postpartum Heart Failure in Mice with Cardiomyocyte-specific Apelin Receptor (APJ) Overexpression.
    Murata K, Ishida J, Ishimaru T, Mizukami H, Hamada J, Saito C, Fukamizu A.
    J Biol Chem; 2016 May 20; 291(21):11241-51. PubMed ID: 27033703
    [Abstract] [Full Text] [Related]

  • 67. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.
    Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, Lawrie KW, Hervieu G, Riley G, Bolaky JE, Herrity NC, Murdock P, Darker JG.
    J Neurochem; 2003 Mar 20; 84(5):1162-72. PubMed ID: 12603839
    [Abstract] [Full Text] [Related]

  • 68. Pancreatic Islet APJ Deletion Reduces Islet Density and Glucose Tolerance in Mice.
    Han S, Englander EW, Gomez GA, Rastellini C, Quertermous T, Kundu RK, Greeley GH.
    Endocrinology; 2015 Jul 20; 156(7):2451-60. PubMed ID: 25965959
    [Abstract] [Full Text] [Related]

  • 69. Translational promise of the apelin--APJ system.
    Barnes G, Japp AG, Newby DE.
    Heart; 2010 Jul 20; 96(13):1011-6. PubMed ID: 20584856
    [Abstract] [Full Text] [Related]

  • 70. Hypoxic Exercise Training Promotes apelin/APJ Expression in Skeletal Muscles of High Fat Diet-Induced Obese Mice.
    Ji W, Gong L, Wang J, He H, Zhang Y.
    Protein Pept Lett; 2017 Jul 20; 24(1):64-70. PubMed ID: 27834140
    [Abstract] [Full Text] [Related]

  • 71. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
    Sato T, Kadowaki A, Suzuki T, Ito H, Watanabe H, Imai Y, Kuba K.
    Int J Mol Sci; 2019 Jan 09; 20(2):. PubMed ID: 30634441
    [Abstract] [Full Text] [Related]

  • 72. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
    Chen X, Bai B, Tian Y, Du H, Chen J.
    J Biol Chem; 2014 Nov 07; 289(45):31173-87. PubMed ID: 25271156
    [Abstract] [Full Text] [Related]

  • 73. PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13.
    Lv D, Li L, Lu Q, Li Y, Xie F, Li H, Cao J, Liu M, Wu D, He L, Chen L.
    Clin Exp Pharmacol Physiol; 2016 May 07; 43(5):569-79. PubMed ID: 26918678
    [Abstract] [Full Text] [Related]

  • 74. The Apelin-APJ axis is an endogenous counterinjury mechanism in experimental acute lung injury.
    Fan XF, Xue F, Zhang YQ, Xing XP, Liu H, Mao SZ, Kong XX, Gao YQ, Liu SF, Gong YS.
    Chest; 2015 Apr 07; 147(4):969-978. PubMed ID: 25375801
    [Abstract] [Full Text] [Related]

  • 75. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
    Fukushima H, Kobayashi N, Takeshima H, Koguchi W, Ishimitsu T.
    J Cardiovasc Pharmacol; 2010 Jan 07; 55(1):83-8. PubMed ID: 19904215
    [Abstract] [Full Text] [Related]

  • 76. Protective effect of Apelin/APJ system on lipopolysaccharide-related cardiac dysfunction.
    Hu J, Huo S, Dou S, Jiang W, Li Y.
    Gen Physiol Biophys; 2021 May 07; 40(3):161-171. PubMed ID: 34100373
    [Abstract] [Full Text] [Related]

  • 77. Interleukin-9 aggravates doxorubicin-induced cardiotoxicity by promoting inflammation and apoptosis in mice.
    Ye D, Wang Z, Xu Y, Ye J, Wang M, Liu J, Zhang J, Zhao M, Chen J, Wan J.
    Life Sci; 2020 Aug 15; 255():117844. PubMed ID: 32464124
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Why don't they beat?: Cripto, apelin/APJ, and myocardial differentiation.
    Kirby ML.
    Circ Res; 2009 Jul 31; 105(3):211-3. PubMed ID: 19644056
    [No Abstract] [Full Text] [Related]

  • 80. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F, Zhou X, Wang L, Shan L, Li C, Zhou H, Lee SM, Hoi MP.
    Eur J Pharmacol; 2018 Feb 05; 820():86-96. PubMed ID: 29229534
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.